Target intelligence / Profile preview

RGL4 pseudogene 1 (RGL4P1)

Target
RGL4P1
Molecular classification
Pseudogene
01

Overview

RGL4 pseudogene 1 (RGL4P1) is a pseudogene related to the protein-coding gene Ral guanine nucleotide dissociation stimulator like 4 (RGL4). Unlike its parental gene, which encodes a guanine nucleotide exchange factor involved in Ras-Raf-MEK-ERK signaling[1], RGL4P1 is classified as a processed or unprocessed pseudogene and is not believed to code for a functional protein[2][3][5]. Pseudogenes can have regulatory roles at the RNA level—such as acting as antisense RNAs, small interfering RNAs, or competing endogenous RNAs (miRNA sponges)—but there is no direct evidence that RGL4P1 has such activity or disease relevance. In general, pseudogenes may influence biological processes by modulating the expression of their parental genes, but they are not conventionally considered drug targets or biomarkers[2][3][5]. There are no known drugs, mechanism-of-action data, or safety concerns associated with RGL4P1. If clinical or functional information about RGL4 pseudogene 1 is required, attention should instead be directed to the protein-coding RGL4 gene, which is involved in signaling pathways but is itself not a common direct therapeutic drug target[1].

Other names
RGL4P1
02

Biological functions

May modulate gene expression through noncoding RNA mechanisms such as miRNA sponge (competing endogenous RNA), antisense RNA, or through effects on RNA stability, though specific data for RGL4P1 is lacking
03

Disease associations

Potential but unconfirmed role in gene regulation networks; no direct evidence for disease association specific to RGL4P1

Beyond the preview

Go deeper on RGL4 pseudogene 1 (RGL4P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RGL4 pseudogene 1 (RGL4P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call